India's Glenmark Life Sciences heads for best day in 6 months
** Shares of active pharmaceutical ingredients maker
Glenmark Life Sciences Ltd GLEM.NS rise as much as 10% to
425.05 rupees, set for its best day since Apr. 5
** GLEM shares touch highest since Sept. 16, up for third
straight session
** More than 778,000 shares change hands by 0642 GMT, 4.3X
the 30-day avg of 182,290 shares
** Stock down 38.8% YTD up to last close, compared with an
8.4% decline in the Nifty Pharma Index .NIPHARM
(Reporting by Anisha Ajith in Bengaluru)
((anisha.ajith@thomsonreuters.com))
Recent news on Alivus Life Sciences
See all newsBrief: Alivus Life Sciences Incorporates Subsidiary Alivus Life Sciences Do Brasil Ltda In Brazil
Brief: Alivus Life Sciences To Buy 76% Stake In Iqgen-X Pharma For Approx 91.2 Million Rupees
India's Alivus rises to 15-month high as brokerages optimistic about drugmaker's annual outlook
India's Alivus Life Sciences rises after quarterly profit increase
Brief: Alivus Life Sciences Ltd March-Quarter Profit 1.63 Billion Rupees